Health insurance costs in the U.S. are on track to rise by another 9 percent in 2026 for employer-sponsored plans. This increase is driven not by insurers’ profits, but by the greater use of medical services. People are accessing more advanced treatments and medications, which means higher bills for everyone.
New medical technologies hold the potential to cut costs, but only if payment reforms prioritize innovation that truly improves patient care. If insurers keep paying for expensive treatments with little added benefit, overall costs will continue to climb.
Insurers often bear the blame for escalating health-care costs. A significant incident occurred in December 2024 when UnitedHealthcare’s CEO was murdered, highlighting public frustration with insurance companies. Many people feel that insurers hinder their access to care. From 2014 to 2024, the average premium for employer-sponsored insurance rose sharply, outpacing inflation. While insurers’ revenues shot up by $657 billion during this period, expenses tied to hospital and medical costs largely drove this increase. In reality, insurance profits accounted for only a small fraction of total health-care spending.
It’s essential to understand that hospital costs play a significant role in overall health spending. In 2023, hospitals accounted for $1.52 trillion of health-care expenses, yet around 80 percent of U.S. hospitals are public or non-profit. The expenses here are often more pronounced in small rural facilities that are struggling financially. In fact, while care costs have risen, average hospital prices have remained stable in real terms over the past decade.
Physician fees aren’t the main driver either. Spending on medical services barely increased after adjusting for inflation, with many doctors’ fees actually declining in real terms. Moreover, prescription drug prices have also stabilized due to the rise in generic medications. From 2009 to 2018, average prices for Medicare drug plan enrollees fell significantly.
However, it’s important to note that health-care costs don’t affect everyone equally. Federal requirements often force drug manufacturers to sell at lower prices to Medicaid patients, leading to price hikes for non-Medicaid patients. Private insurers pay about 2.5 times what Medicare pays for hospital care. The way payments are structured tends to favor facilities with prestige and cutting-edge technology, which can inflate prices further.
More directly, the sheer demand for medical care in America is a huge contributing factor to rising costs. The U.S. uses significantly more medical services than other countries. A 2020 report from the OECD revealed that the U.S. spends three times more on health care than the average developed nation. Higher usage—220 percent of the average—is a notable reason for these costs. A recent study in the *Journal of the American Medical Association* found that county-level health-care spending was largely explained by how much care people accessed, not just pricing.
Since 2014, there’s been a 20 percent increase in medical service utilization for both public and private insurance holders. The number of medical practitioners has seen a rise from 6.5 million to nearly 9.6 million in the same timeframe. While more care is available, it also means more people are being treated at a higher cost, especially for surgeries and state-of-the-art procedures. For example, the demand for total knee replacements and other intensive treatments has surged in recent years.
The future of health-care costs and technological advancements hinges on policy decisions. Many in tech circles believe that AI and other innovations could enhance treatment efficacy while slashing expenses. AI can analyze extensive medical research data and assist in diagnostic processes, making health care more efficient. However, safety concerns and the potential for increased costs remain challenges to full adoption.
Ultimately, unless health policies are revised to prioritize cost-effective innovations, expenses will continue to soar. For example, when newly developed medications are priced excessively with little added clinical value, it strains the system. By changing how Medicare and Medicaid reimburse for new technologies, policymakers may encourage a focus on cost-saving innovations without overburdening the system.
In conclusion, the story of rising health-insurance costs is tied not just to inefficient administration or hospital greed, but to our increasing appetite for diverse and innovative medical care. Addressing this fundamental issue will require thoughtful reform and a reevaluation of how we incentivize health care in America.
